Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study.

Benesch, M; McDonald, G B; Schubert, M; Appelbaum, F R; Deeg, H J

Benesch, M; McDonald, G B; Schubert, M; Appelbaum, F R; Deeg, H J.

Affiliation

Benesch M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Bone Marrow Transplant ; 32(11): 1071-5, 2003 Dec.

Article in En | MEDLINE | ID: mdl-14625578

Subject(s)

Amifostine/pharmacology; Cytoprotection/drug effects; Hematopoietic Stem Cell Transplantation/methods; Myelodysplastic Syndromes/therapy; Transplantation Conditioning/adverse effects; Adult; Amifostine/administration & dosage; Amifostine/therapeutic use; Busulfan/administration & dosage; Cause of Death; Hematopoietic Stem Cell Transplantation/adverse effects; Hematopoietic Stem Cell Transplantation/mortality; Humans; Middle Aged; Myeloablative Agonists/administration & dosage; Myelodysplastic Syndromes/complications; Myelodysplastic Syndromes/mortality; Pilot Projects; Siblings; Transplantation Conditioning/methods; Transplantation Conditioning/mortality; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Amifostine / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Cytoprotection Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2003 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links